Table 4.

Multivariate analysis of TTP and OS following third-line chemotherapy

Clinical factors	TTP P value	OS P value
Age (<60 vs. ≥60)	0.59	0.76
PS (0.1 vs. 2.3)	0.006	0.005
Pathology (mucinous/clear cell vs. non-mucinous/clear cell)	0.34	0.29
No. of target lesions (1 vs. 2.3)	0.85	0.79
Primary DFI (<6 months vs. ≥6 months)	0.01	0.004
Secondary DFI (<6 months vs. ≥ 6 months)	0.61	0.34
Response to second-line therapy (responder vs. non-responder)	0.43	0.17
PT regimens (PT regimens vs. non-PT regimens)	0.84	0.36

DFI Drug free-interval, PT Platinum/taxane